Typing of human papillomavirus in Zimbabwean patients with invasive cancer of the uterine cervix

References

• Zur Hausen H. Papilloma viruses in human cancer. Cancer 1987; 59: 1692–6.
   Google Scholar
• De Villiers E-M. Human pathogenic papillomavirus types: an update. Curr Opin Microbiol Immunol 1994; 108: 2–9.
   Google Scholar
• Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12–19.
   Google Scholar
• Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Schiffman MH et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87: 796–802.
   Google Scholar
• Lane DP. Cancer p53, guardian of the genome. Nature 1992; 358: 15–16.
   Google Scholar
• Massimi P, Banks L. Repression of p53 transcriptional activity by the HPV E7 proteins. Virology 1997; 227: 255–9.
   Google Scholar
• Spitkovsky D, Hehner SP, Hofmann TG, Moller A, Schmitz ML. The human papillomavirus oncoproteins E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex. J Biol Chem 2002; 277: 25576–82.
   Google Scholar
• Filippova M, Song H, Connolly JL, Dermody TS, Duerksen-Hughes PJ. The human papillomavirus 16 E6 protein binds to TNF R1 and protects cell from TNF-induced apoptosis. J Biol Chem 2002; 277: 21730–9.
   Google Scholar
• Williamson A-L, Brink NS, Dehaeck CMC, Ovens S, Soeters R, Rybicki EP. Typing of human papillomaviruses in cervical carcinoma biopsies from Cape Town. J Med Virol 1994; 43: 231–7.
   Google Scholar
• Matsukura T, Sugase M. Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinico pathologic lesions. Int J Cancer 1995; 61: 13–22.
   Google Scholar
• Torroella-Kouri M, Morsberger S, Carrillo A, Mohar A, Meneses A, Ibarra M et al. HPV prevalence among Mexican women with neoplastic and normal cervixes. Gynecol Oncol 1998; 70: 115–20.
   Google Scholar
• Schmauz R, Okong P, de Villiers E-M, Dennin R, Brade L, Lwanga SK et al. Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. Int J Cancer 1989; 43: 805–9.
   Google Scholar
• Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92: 464–74.
   Google Scholar
• Sebbelov AM, Davidson M, Kruger Kjaer S, Jensen H, Gregoire L, Hawkins I et al. Comparison of human papillomavirus genotypes in archival cervical cancer specimens from Alaska natives, Greenland Natives and Danish Caucasians. Microbes Infect 2000; 2: 121–6.
   Google Scholar
• Lo KW, Cheung TH, Chung TK, Wang VW, Poon JS, Li JC et al. Clinical and prognostic significance of human papillomavirus in Chinese population of cervical cancers. Gynecol Obstet Invest 2001; 51: 202–7.
   Google Scholar
• Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594–606.
   Google Scholar
• Williamson A-L, Rybicki EP. Detection of genital human papillomavirus by polymerase chain reaction amplification with degenerated nested primers. J Med Virol 1991; 33: 165–71.
   Google Scholar
• Kay P, Meehan K, Williamson A-L. The use of nested polymerase chain reaction and restriction fragment length polymorphism for the detection and typing of mucosal human papillomaviruses in samples containing low copy numbers of viral DNA. J Virol Methods 2002; 105: 159–70.
   Google Scholar
• Durst M, Gissman L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983; 80: 3812–5.
   Google Scholar
• Ter Meulen J, Eberhardt HC, Luande J, Mgaya HN, Chang-Claude J, Mtiro H et al. Human papillomavirus (HPV) infection and cervical cancer in Tanzania, East Africa. Int J Cancer 1992; 51: 515–21.
   Google Scholar
• Chabaud M, Le Cann P, Mayelo V, Leboulleux D, Diallo AS, Enogat N et al. Detection by PCR of human papillomavirus genotypes in cervical lesions of Senegalese women. J Med Virol 1996; 49: 259–63.
   Google Scholar
• Buonaguro FM, Tornesello ML, Salatiello I, Okong P, Buonaguro L, Beth-Giraldo E et al. The Uganda study on HPV variants and genital cancer. J Clin Virol 2000; 19: 31–41.
   Google Scholar
• Thomas DB, Qin Q, Kuypers J, Kiviat N, Ashley RL, Koetsawang A et al. Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas. Am J Epidemiol 2001; 153: 732–9.
   Google Scholar
• Dreier B, Bachtiary B, Birner P, Potter R, Selzer E. Influence of human papillomavirus-infection on cervical cancer in patients undergoing radiotherapy. (Abstract ID 335.) 18th International HPV Conference, Barcelona, Spain, 2000.
   Google Scholar
• Huang S, Afonina I, Miller BA, Beckman AM. Human papillomavirus type 52 and 58 are prevalent in cervical cancer from Chinese women. Int J Cancer 1997; 70: 408–11.
   Google Scholar